April 20, 2014 9:49 AM ET

Capital Markets

Company Overview of Flagship Ventures

Company Overview

Flagship Ventures is a venture capital firm specializing in incubation, seed stage, early, later and growth stage investments. The firm prefers to invest in the healthcare including biotherapeutics, medical technologies, biological discoveries leading to new therapies, advanced analysis for improved medicine, chemistries and small molecule drugs, nanotechnology for medicine; energy efficiency; bioenergy; sustainability; and cleantechnology sector. The firm seeks to invest in Midwest. It seeks to initially invest between $500,000 and $5 million, with a typical investment between $7 million and $15 million as part of a syndicate in its portfolio companies. The firm typically makes an initial i...

One Memorial Drive

7th Floor

Cambridge, MA 02142

United States

Founded in 2000

Phone:

617-868-1888

Fax:

617-868-1115

Key Executives for Flagship Ventures

Co-Founder
Age: 50
Co-Founder
Age: 56
Chief Financial Officer
Age: 42
Chief Operating Officer and General Partner
Age: 58
Partner and Chief Business Officer
Age: 59
Compensation as of Fiscal Year 2013.

Flagship Ventures Key Developments

Flagship Ventures Appoints Stephane Bancel as Senior Partner

Flagship Ventures announced the appointment of Stephane Bancel as a Senior Partner. In this role, Mr. Bancel will provide strategic counsel and support to portfolio companies. Prior to joining Flagship, Mr. Bancel served as Chief Executive Officer of bioMerieux. In addition to working closely with companies in the portfolio, Mr. Bancel also serves as President and Chief Executive Officer of Moderna Therapeutics.

Flagship Ventures Presents at Boston Biotech Conference, Apr-03-2013 04:00 PM

Flagship Ventures Presents at Boston Biotech Conference, Apr-03-2013 04:00 PM. Venue: Four Seasons Hotel, 200 Boylston Street, Boston, MA 02116, United States. Speakers: Douglas G. Cole, General Partner and Partner.

Flagship Ventures Presents at Boston Biotech Conference CEO New York Conference, Nov-02-2012 11:30 AM

Flagship Ventures Presents at Boston Biotech Conference CEO New York Conference, Nov-02-2012 11:30 AM. Venue: Apella, 450 East 29th Street, New York, NY 10016, United States. Speakers: Douglas G. Cole, General Partner and Partner.

Similar Private Companies By Industry

Company Name Region
Grassmere Acquisition Corporation United States
United Global Advisors, LLC United States
The Bridgeford Group, Inc. United States
Nova Northwest United States
Stone Key Group LLC United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
April 2, 2014
Acceleron Pharma, Inc.
Private Placement
February 13, 2014
Pronutria, Inc.
Merger/Acquisition
January 22, 2014
REG Life Sciences, LLC
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Flagship Ventures, please visit www.flagshipventures.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.